Health Economics & Outcomes Research Fellowships
Overview & Purpose
Thomas Jefferson University has offered industry-sponsored fellowships in health economics and outcomes research (HEOR) since 1994. The fellowships are administered through the Jefferson College of Population Health (JCPH), which is the nation's first college of population health in the country.
The goal of the fellowship program is to prepare pharmacists and other health professionals for careers in health economics and outcomes research. One of the oldest and most established programs of its kind in the country, the JCPH fellowship program has more than 50 alumni to date. Current industry sponsors include Ethicon, Novartis Pharmaceuticals, Inc., Otsuka, Teva Pharmaceuticals and United Therapeutics Corporation.
HEOR Fellowship Information Session
If you missed our recent information sessions, you can view a recording, which includes an overview of the program with presentations and discussions featuring our program director and current fellows.
General Information
- All JCPH fellowships are 2-years long and begin in June.
- Fellows are assigned a JCPH faculty mentor who advises them and supervises their progress throughout the course of the fellowship.
- Fellows usually spend the first year on the Jefferson campus in downtown Philadelphia, PA. Fellows apply the skills and knowledge gained from formal coursework to their research projects.
- Financial support from the industry sponsor allows Fellows to complete a JCPH graduate certificate or master’s degree in Applied Health Economics & Outcomes Research, Health Policy, Population Health, Population Health Intelligence, Operational Excellence or Healthcare Quality & Safety during the duration of the fellowship.
- Fellows work on JCPH outcomes research projects and acquire management experience. Fellows are encouraged to produce publications and make presentations based on these projects at professional meetings.
- Fellows typically spend the second year working at the site of the industry sponsor. This provides experience in outcomes research in a corporate setting and offers opportunities to see first-hand how policies affect various stakeholders within the industry.
Eligibility
Fellows are selected from an international pool of candidates with scientific and/or clinical training in health care (e.g., biomedical engineering, nursing, medicine, public health, epidemiology, health economics, health policy, pharmacy) and a stated interest in HEOR. Preference is given to individuals who have prior graduate training and experience in healthcare or HEOR, but this is not a requirement.
Outcomes
Upon completion of the HEOR fellowships, alumni have the skills to:
- Apply research principles and applications to the evaluation of healthcare interventions.
- Analyze the policy implications of health outcomes research findings.
- Analyze and employ the measurement of healthcare quality, safety and cost in various healthcare settings.
- Examine the costs of medical and pharmaceutical care as seen from a variety of perspectives, including health plans, managed care organizations, pharmaceutical and device industries, and academia.
- Assume leadership roles in the management of HEOR projects in a variety of healthcare settings.
Industry Sponsors
The Ethicon Franchise Health Economics & Market Access (HEMA) Fellowship provides training on the skills and insights necessary for a successful career in HEOR and market access in medical device industry. After six months of research experience at Thomas Jefferson University, the fellow will join the Ethicon Franchise HEMA team in Raritan, NJ or Cincinnati, OH. Valuable experience will be gained by conducting research to support health policy decisions and improve patient outcomes. In addition to project work, the fellow will participate in and lead meetings with cross-functional partners, and further develop networking and presentation skills conducive to successfully developing and marketing Ethicon’s product and specialty portfolio.
The Novartis Fellowship focuses on the assessment of therapeutic interventions and provides experience in using clinical, economic and humanistic data to support the research, development, adoption and utilization of pharmaceutical products. In their second year, fellows work in Novartis’ Health Economics & Outcomes Research Department, located in New Jersey, and also interact with other Novartis departments to learn how outcomes research generates evidence of the value of Novartis products.
This two-year Fellowship will provide Fellows with training and exposure to various aspects of HEOR in both industry and academic settings. The program is designed to facilitate and empower the Fellow in learning and succeeding in the challenging global healthcare more. During the second year, the Fellow will complete their participation at the Ostuka office in Princeton, New Jersey.
The Teva Fellowship is designed to facilitate and empower the fellow in learning and succeeding in the challenging global healthcare market. During the second year of the fellowship, fellows will work directly with the Global Health Economics and Outcomes Research (GHEOR) team to conduct outcomes research, generating evidence of the value of Teva products. In addition to project work, the fellow will participate in meetings with cross-functional partners and further develop networking and presentation skills among R&D, medical affairs, and commercial colleagues.
The United Therapeutics Fellowship will focus on how clinical, economic, and humanistic evidence is disseminated to internal and external stakeholders to support commercialization and market access strategy. Fellows will lead strategic initiatives and research projects and conduct advisory boards with prescribers, payers, and patients to test the value proposition of commercialized products and products in development. During their second year, Fellows will work with the Global Medical Affairs, Health Economics and Outcomes Research team at the Research Triangle Park, North Carolina office.
Questions concerning the HEOR Fellowships should be addressed to [email protected].